Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 2/20 | 0.50 |
| ▸ | HMGCR | P04035 | 1/20 | 0.50 |
| ▸ | CYP1A1 | P04798 | 5/20 | 0.40 |
| ▸ | CYP1B1 | Q16678 | 5/20 | 0.40 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.39 |
| ▸ | TYR | P14679 | 1/20 | 0.39 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.39 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.39 |
| ▸ | ABCG2 | Q9UNQ0 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | TP53 | P04637 | 1/20 | 0.38 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | HPGD | P15428 | 1/20 | 0.36 |
| ▸ | ATM | Q13315 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28308893 | 0.82 | CYP3A4 (0.46) | CYP3A4HMGCRCYP1A1CYP1B1CYP1A2 | |
| SCHEMBL38650708 | 0.82 | CYP1A1 (0.39) | CYP1A1CYP1B1CYP1A2NFE2L2CYP19A1 | |
| SCHEMBL7862304 | 0.79 | CYP1A1 (0.61) | CYP3A4HMGCRCYP1A1CYP1B1CYP1A2 | |
| SCHEMBL14518617 | 0.79 | CYP1A1 (0.61) | CYP3A4HMGCRCYP1A1CYP1B1CYP1A2 | |
| SCHEMBL5451938 | 0.79 | XDH (0.44) | CYP1A1CYP1B1CYP1A2NFE2L2ABCG2 | |
| SCHEMBL29953692 | 0.77 | ALDH1A1 (0.52) | TYRTSHRKDM4EALDH1A1 | |
| SCHEMBL9311231 | 0.77 | ALDH1A1 (0.37) | CYP1A1CYP1B1CYP1A2NFE2L2CYP19A1 | |
| SCHEMBL851964 | 0.77 | ALDH1A1 (0.52) | TYRTSHRKDM4EALDH1A1 | |
| SCHEMBL1635785 | 0.76 | ACHE (0.52) | CYP3A4CYP1A2TSHRKDM4EALDH1A1 | |
| SCHEMBL29793327 | 0.76 | ACHE (0.52) | CYP3A4CYP1A2TSHRKDM4EALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11566035-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2023-01-31 | — | — | US | disclosed |
| US-20210332072-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2021-10-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210332072-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | OCIAD1, OSBP, OCIAD2 | CYP3A4 263/4885HMGCR 916/4885CYP1A1 191/4885 |
| US-11566035-B2 | Organic electroluminescent materials and devices | OCIAD1, OSBP, OCIAD2 | CYP3A4 263/4885HMGCR 916/4885CYP1A1 191/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.